https://ift.tt/3jEOs4K The World Health Organisation’s technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final “risk-benefit assessment” for Emergency Use Listing of the vaccine.
WHO delays Covaxin approval, seeks additional clarifications from Bharat Biotech
Reviewed by MITESH
on
October 26, 2021
Rating: 5
No comments